Drugs / TDV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06060067 | Mar 2024 → May 2025 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06060067 ↗ |
| Modality | Vaccine | “The vaccine being tested in this study is called TDV (Live, Attenuated).” NCT06060067 ↗ |